Results 211 to 220 of about 667,198 (303)
Advancing the science and care of pulmonary hypertension, globally. [PDF]
Giannakoulas G +2 more
europepmc +1 more source
ABSTRACT Background Advanced heart failure (HF) remains a clinical challenge, and mitral transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a potential bridging strategy. Aims To describe the clinical outcomes of M‐TEER in a single‐center cohort of patients with advanced HF and to identify anatomical and clinical features potentially associated ...
Pedro Castilhos de Freitas Crivelaro +8 more
wiley +1 more source
ABSTRACT Background Development of conduction abnormalities requiring pacing after transcatheter aortic valve replacement (TAVR) is relatively common. The effects of post‐TAVR permanent pacemaker (PPM) implantation on mortality, ischemic stroke, and cardiovascular outcomes remain incompletely characterized.
Omar Saleh +7 more
wiley +1 more source
Roles of Lipid Metabolism in Pulmonary Hypertension: Friend or Foe? [PDF]
Huang W +7 more
europepmc +1 more source
Early Results of Sotatercept Treatment in Patients With Severe Pulmonary Hypertension and a Potts Shunt. [PDF]
Aggarwal MA +3 more
europepmc +1 more source
ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa +3 more
wiley +1 more source
Pulmonary arterial hypertension exacerbated by ruxolitinib
Andrew T. Low +3 more
doaj +1 more source
Haemodynamics and post-exercise recovery response in chronic obstructive pulmonary disease-pulmonary hypertension and interstitial lung disease-pulmonary hypertension: An appraisal. [PDF]
Deshmukh SN, Anand A, Deore SS.
europepmc +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source

